Wellington Management Group LLP Invitae Corp Transaction History

Wellington Management Group LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $26.2 Million - $65.1 Million	-4,178,329 Reduced 96.49%	151,944 $1.21 Million
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $796,798 - $1.55 Million	-54,204 Reduced 1.24%	4,330,273 $66.1 Million
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $107 Million - $147 Million	4,384,477 New	4,384,477 $125 Million
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $7.69 Million - $13.2 Million	-232,712 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $781,526 - $1.15 Million	19,993 Added 9.4%	232,712 $9.73 Million

Q3 2020 Nov 16, 2020	SELL	$28.43 - $44.67 $29 Million - $45.6 Million	-1,020,158 Reduced 82.75%	212,719 $9.22 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $8.33 Million - $21.5 Million	711,358 Added 136.4%	1,232,877 $37.3 Million
Q1 2020 May 14, 2020	SELL	$7.64 - $27.5 $72,007 - $259,187	-9,425 Reduced 1.78%	521,519 $7.13 Million
Q4 2019 Feb 11, 2020	BUY	$15.02 - $20.57 $7.97 Million - $10.9 Million	530,944 New	530,944 $8.57 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.